Scholarlink

Background and objective <p>This study aimed to elucidate the role of insulin resistance in the progression from non-alcoholic fatty liver disease (NAFLD) to cardiovascular-kidney-metabolic (CKM) diseases, and to explore the potential influence of lifestyle factors.</p> Methods <p>This study included participants free of NAFLD and CKM diseases from the UK Biobank. Insulin resistance was assessed using the TyG index. CKM diseases include ischemic stroke (IS), ischemic heart disease (IHD), type 2 diabetes (T2D), and chronic kidney disease (CKD). Markov multi-state models were used to assess the associations between the TyG index and disease transitions.</p> Results <p>Among 377,757 participants (median age 57&#xa0;years), 4949 developed NAFLD over a median follow-up of 13.6&#xa0;years. Of these, 12.65% progressed to T2D, 9.11% to IHD, 8.63% to CKD, and 4.61% to IS. Elevated TyG levels significantly accelerated transitions from NAFLD to first-onset CKM disease (HR = 1.25, 95% CI 1.05–1.49), double CKM disease (HR = 1.46, 95% CI 1.19–1.80), and triple CKM disease (HR = 1.81, 95% CI 1.28–2.55). Similar progression risk increases were observed for individual CKM components: T2D (HR = 1.41, 95% CI 1.11–1.78), CKD (HR = 1.37, 95% CI 1.08–1.75), and IS (HR = 1.70, 95% CI 1.27–2.27). A J-shaped dose–response relationship was identified. Transitions risk remained pronounced among individuals with healthy sleep and regular physical activity.</p> Conclusions <p>Insulin resistance independently accelerated the progression from NAFLD to CKM diseases, particularly ischemic stroke. Healthy sleep and regular physical activity failed to offset this detrimental impact.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The role of insulin resistance in the longitudinal progression from NAFLD to cardiovascular-kidney-metabolic disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月15日

查看全文
  • Chao Hou,
  • Xiangling Yuan,
  • Min Peng,
  • Xuan Shi,
  • Dahong Yang,
  • Fang Wang,
  • Ke Song,
  • Gelin Xu,
  • Jianzhong Shi

摘要

Background and objective

This study aimed to elucidate the role of insulin resistance in the progression from non-alcoholic fatty liver disease (NAFLD) to cardiovascular-kidney-metabolic (CKM) diseases, and to explore the potential influence of lifestyle factors.

Methods

This study included participants free of NAFLD and CKM diseases from the UK Biobank. Insulin resistance was assessed using the TyG index. CKM diseases include ischemic stroke (IS), ischemic heart disease (IHD), type 2 diabetes (T2D), and chronic kidney disease (CKD). Markov multi-state models were used to assess the associations between the TyG index and disease transitions.

Results

Among 377,757 participants (median age 57 years), 4949 developed NAFLD over a median follow-up of 13.6 years. Of these, 12.65% progressed to T2D, 9.11% to IHD, 8.63% to CKD, and 4.61% to IS. Elevated TyG levels significantly accelerated transitions from NAFLD to first-onset CKM disease (HR = 1.25, 95% CI 1.05–1.49), double CKM disease (HR = 1.46, 95% CI 1.19–1.80), and triple CKM disease (HR = 1.81, 95% CI 1.28–2.55). Similar progression risk increases were observed for individual CKM components: T2D (HR = 1.41, 95% CI 1.11–1.78), CKD (HR = 1.37, 95% CI 1.08–1.75), and IS (HR = 1.70, 95% CI 1.27–2.27). A J-shaped dose–response relationship was identified. Transitions risk remained pronounced among individuals with healthy sleep and regular physical activity.

Conclusions

Insulin resistance independently accelerated the progression from NAFLD to CKM diseases, particularly ischemic stroke. Healthy sleep and regular physical activity failed to offset this detrimental impact.

Graphical abstract